Vantage logo

Ascendis shoots higher on pivotal win 

Shares in the company surge after its weekly growth hormone treatment proves superior to daily injections, raising broader hopes for Ascendis’s long-acting technology.

Vantage logo

Eidos chases Pfizer in amyloidosis

Eidos presses ahead in its David and Goliath battle against Pfizer in amyloidosis, but it could have issues with pivotal trial recruitment.